Central Effects of Peripherically Introduced Immune Cells Modulated by an Original Anticonvulsant in Experimental Alcoholism

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Violation of neuroimmune regulatory interrelation, caused, in particular, by a change in the immune cell’s functional phenotype due to chronic ethanol intoxication, is an essential link in the pathogenesis of alcoholism. The unidirectional influence of most psychoactive drugs on the cells of the nervous and immune systems allows to consider immune cells as model objects for influencing intersystem functional interrelation. Based upon our own priority data on the presence of immunomodulatory properties in chronic alcohol intoxication at the original anticonvulsant acting on the molecular targets of ethanol influence in the central nervous system and the immune system, the aim of the present study was to evaluate the central effects of peripherally injected lymphocytes with in vitro modulated functional activity by a synthetic ligand of the GABAA-receptor complex meta-chlorobenzhydrylurea in long-term alcoholized animals. It was shown that transplantation of lymphocytes pre-cultivated with the anticonvulsant in syngeneic long-term alcoholic recipients achieves a decrease in alcohol motivation and stimulation of behavioral activity in the “open field” test. Editing of behavioral patterns characteristic for chronic alcohol intoxication was recorded against the background of a decrease in pathogenetically significant brain structures of pro-inflammatory cytokines IL-1β, IL-6, TNF-α, IFN-γ and an increase in the anti-inflammatory cytokine IL-10, as well as an increase in the level of BDNF in the hippocampus, which allows us to consider a decrease in neuroinflammation and stimulation neuroplasticity as possible mechanisms for editing the behavior of recipients. Visualization of functionally active lymphocytes pre-cultured with meta-chlorobenzydrylurea in the brain’s parenchyma of long-term alcoholized recipients also suggests a direct effect of injected lymphocytes on CNS cells. Thus, immune cells modulated in vitro with meta-chlorobenzydrylurea by relatively independent mechanisms have positive psychoneuromodulating effects in chronic ethanol intoxication, which makes it possible to consider adoptive immunotherapy as a promising method in the treatment of alcoholism.

Sobre autores

E. Markova

Federal State Budgetary Scientific Institution “Research Institute
of Fundamental and Clinical Immunology”

Email: nchjournal@gmail.com
Russia, Novosibirsk

I. Savkin

Federal State Budgetary Scientific Institution “Research Institute
of Fundamental and Clinical Immunology”

Email: nchjournal@gmail.com
Russia, Novosibirsk

E. Serenko

Federal State Budgetary Scientific Institution “Research Institute
of Fundamental and Clinical Immunology”

Email: nchjournal@gmail.com
Russia, Novosibirsk

M. Knyazheva

Federal State Budgetary Scientific Institution “Research Institute
of Fundamental and Clinical Immunology”

Email: nchjournal@gmail.com
Russia, Novosibirsk

Yu. Shevchenko

Federal State Budgetary Scientific Institution “Research Institute
of Fundamental and Clinical Immunology”

Email: nchjournal@gmail.com
Russia, Novosibirsk

Bibliografia

  1. Анохина И.П. //Вопросы наркологии. 2018. № 2. С. 22–34.
  2. Ward R.J., Lallemand F., De Witte P. //Alcohol & Alcoholism. 2009. V. 44 (2). P. 128–135.
  3. Kelleya K.W., Dantzer R. // Brain. Behav. Immun. 2011. V. 25 (S1). P. S13–S20.
  4. Crews F.T., Lawrimore C.J., Walter T.J., Coleman L.G. // Neuropharmacol. 2017. V. 122. P. 56–73.
  5. Meredith L.R., Burnette E.M., Grodin E.N., Irwin M.R., Ray L.A. // Brain. Behav. Immun. 2021. V. 97. P. 349–364.
  6. Blaine S.K., Sinha R. // Neuropharmacol. 2017. V. 122. P. 136–147.
  7. Pérez-Reytor D., Karahanian E. // The American Journal of Drug and Alcohol Abuse. 2022. https://doi.org/10.1080/00952990.2022.2114005
  8. Follesa P., Floris G., Asuni G.P., Ibba A., Tocco M.G., Zicca L., Gorini G. // Front. in Cell. Neurosci. 2015. V. 9. P. 445.
  9. Centanni S.W., Teppen T., Risher M.-., Fleming, R.L., Moss J.L., Acheson S.K. et al. // Alcohol. Clin. Exp. Res. 2014. V. 38. P. 2800–2808.
  10. Alam S., Walding A // Mol. Immunol. 2006. V. 43. № 9. P. 1432–1442.
  11. Mendu S.K., Akesson L., Jin Z., Edlund A., Cilio C., Lernmark A., Birnir B. // Mol. Immunol. 2011. V. 48. № 4. P. 399–407.
  12. Zhang H., Meadows G.G. // J. Leukocyte Biol. 2005. V. 78. № 5. P. 1070–1080.
  13. Zuluaga P., Sanvisens A., Caceres E.M., Muga R. // Drug and Alcohol Dependence. 2017. V. 180. P. 7–13.
  14. Sureshchandra S., Raus A., Jankeel A., Ligh B.J.K., Walter N.A., Newman N., Messaoudi I. // Scientific Reports. 2019. V. 9. № 1. P. 1–13.
  15. Pang M., Bala S., Kodys K., Catalano D., Szabo G. // BMC Immunology. 2011. V. 12. № 1. P. 1–11.
  16. Crews F.T., Sarkar D.K., Qin L., Zou J., Boyadjieva N., Vetreno R.P. // Alcohol Res. 2015. V. 37. P. 331–351.
  17. Boyd K.N., Kumar S., O’Buckley T.K. // J. Neurochem. 2010. V. 112. № 3. P. 784–796.
  18. Evseev V.A., Davydova T.V., Mikovskaya O.I. // Bull. Exp. Biol. Med. 2001. V. 131. № 4. P. 364–368.
  19. Shushpanova T.V., Solonsky A.V., Bokhan N.A., Novozheeva T.P., Udut V.V., Arbit G.A., Filimonov V.D. // J. Alcohol Drug Depend. 2016. V. 4. № 234. P. 2.
  20. Novozheeva T., Markova E., Shushpanova O., Knyazeva E., Shushpanova T. // European Psychiatry. 2019. V. 56. P. S15.
  21. Маркова Е.В., Савкин И.В., Шушпанова Т.В., Княжева М.А., Аникеева О.С. // Изобретения и полезные модели. Официальный бюллетень федеральной службы по интеллектуальной собственности. 2019. № 17. RU 2691143 C1.
  22. Markova E., Savkin I., Anikeeva O., Shushpanova T. // European Psychiatry. 2019. V. 56(S). P. 662–663.
  23. Markova E., Knyazheva M., Savkin I., Shushpanova T. // European Psychiatry. 2017. V. 41(S1). P. 742–743.
  24. Markova E.V., Savkin I.V., Knyazheva M.A., Shushpanova T.V. //Siberian Herald of Psychiatry and Addiction Psychiatry. 2020. V. 1 (106). P. 14–22 (in Rus).
  25. Markova E., Starostina M., Abramov V., Kozlov V. / Proceedings of the 2nd European Congress of Immunology. Free Papers. Editors Reinhold E. Schmidt. MEDIMOND S.r.l., Bolonga, Italy. 2009. P. 423–429.
  26. Markova E.V., Knyazheva M.A. // Medical Immunology (Russia). 2021. V. 23 (4). P. 699–704.
  27. Markova E.V., Knyazheva M.A., Tikhonova M.A., Amstislavskaya T.G. // Neurosci. Lett. 2022. V. 786. P. 136790.
  28. Markova E.V., Serenko E.V. // Siberian Herald of Psychiatry and Addiction Psychiatry. 2022. V. 3 (116). P. 5–13 (in Rus).
  29. Rattazzi L. Piras G., Ono M., Deacon R., Pariante C.M., Acquisto F.D. // Transl. Psychiat. 2013. V. 3. P. 280.
  30. Radjavi A., Smirnov I., Kipnis J. // Brain Behav. Immun. 2014. V. 35. P. 58–63.
  31. Song C. Nicholson J.D., Clark S.M., Li X., Keegan A.D., Tonelli L.H. // Brain Behav. Immun. 2016. V. 57. P. 161–172.
  32. Clark S.M., Vaughn C.N., Soroka J.A., Li Xi. Tonelli L.H. // Eur. J. Neurosci. 2018. V. 47. P. 968–978.
  33. Буреш Я., Бурешова О., Хьюстон Д.П. / Методики и основные эксперименты по изучению мозга и поведения. М., 1991. 399 с.
  34. Prasad S., Hu S., Sheng W.S., Singh A., Lokensgard J.R. // PLoS One. 2015. V. 10. № 12. P. e0145457.
  35. Crews, F.T., Collins M.A., Dlugos C., Littleton J., Wilkins L., Neafsey E.J., Noronha A. // Alcoholism: Clinical and Experimental Research. 2004. V. 28. № 2. P. 350–364.
  36. Topiwala, A., Allan, C.L., Valkanova, V., Zsoldos, E., Filippini, N., Sexton, C., Mahmood, A., Fooks, P., Singh-Manoux, A., Mackay, C.E., Kivimäki, M., Ebmeier, K.P. // BMJ. 2017. V. 357. P. j2353.
  37. Lowe P.P., Morel C., Ambade A., Iracheta-Vellve A., Kwiatkowski E., Satishchandran A., Szabo G. // J. Neuroinflammation. 2020. V. 17. P. 1–18.
  38. Flores-Bastías O., Karahanian E. // Neuropharmacol. 2018. V. 128. P. 401–407.
  39. Airapetov M., Eresko S., Lebedev A., Bychkov E., Shabanov P. // Biosci. Trends. 2021. V. 15. № 2. P. 74–82.
  40. Aurelian L., Balan I. // Psychopharmacol. 2019. V. 236. P. 3023–3043.
  41. Logrip M.L., Barak S., Warnault V., Ron D. // Brain Res. 2015. V. 1628. P. 60–67.
  42. Ceballos N., Sharma S. // AIMS Neurosci. 2016. V. 3. № 4. P. 398–432.
  43. Peregud D.I., Panchenko L.F., Gulyaeva N.V. // J. Addict. Problems. 2016. № 9–10. P. 29–41 (in Rus).
  44. Feltenstein M.W., See R.E. // Cold Spring Harbor Perspectives in Medicine. 2013. V. 3. № 5. P. a011916.
  45. Popova N.K., Ilchibaeva T.V., Antonov E.V., Pershina A.V., Bazovkina D.V., Naumenko V.S. // Alcohol. 2020. V. 87. P. 1–15.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar
2.

Baixar (66KB)
Metadados
3.

Baixar (236KB)
Metadados
4.

Baixar (619KB)
Metadados

Declaração de direitos autorais © Е.В. Маркова, И.В. Савкин, Е.В. Серенко, М.А. Княжева, Ю.А. Шевченко, 2023

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies